Insider Souvik Das plans sale of 10,000 shares

CWAN insider Souvik Das filed a Form 144 notice to sell 10,000 shares of common stock through Morgan Stanley Smith Barney LLC around 02/09/2026, with an aggregate market value of 238,500.00 on the NYSE.

Rhea-AI Filing Summary

CWAN insider Souvik Das filed a Form 144 notice to sell 10,000 shares of common stock through Morgan Stanley Smith Barney LLC around 02/09/2026, with an aggregate market value of 238,500.00 on the NYSE.

The 10,000 shares to be sold were acquired as restricted stock units from the issuer on 02/28/2024. The issuer had 288,632,000 shares of common stock outstanding. In the past three months, Das and related 10b5-1 labeled accounts reported several prior sales of common shares with disclosed gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CWAN Form 144 filing by Souvik Das disclose?

The filing discloses that insider Souvik Das plans to sell 10,000 CWAN common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of 238,500.00. The planned sale is expected around 02/09/2026 on the NYSE.

How many CWAN shares is Souvik Das planning to sell under Form 144?

Souvik Das plans to sell 10,000 CWAN common shares. The filing lists an aggregate market value of 238,500.00 for this block, to be sold through Morgan Stanley Smith Barney LLC on or about 02/09/2026 on the NYSE.

When and how did Souvik Das acquire the CWAN shares being sold?

The 10,000 CWAN shares being sold were acquired as restricted stock units from the issuer on 02/28/2024. The filing shows the amount of securities acquired as 10,000 common shares, with the date of payment also listed as 02/28/2024.

What CWAN trading history is reported for Souvik Das in the last 3 months?

The filing lists several prior CWAN common share sales over the past three months, including 20,000 shares on 11/12/2025 and 10,000 shares on 12/08/2025, each with disclosed gross proceeds. Some entries are labeled as 10b5-1 sales for Souvik Das.

How many CWAN shares are outstanding according to this Form 144?

The Form 144 reports that 288,632,000 CWAN common shares are outstanding. This provides context for the 10,000-share block that Souvik Das plans to sell, which is being executed through Morgan Stanley Smith Barney LLC on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 04:31 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001879939
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clearwater Analytics Holdings, Inc.
SEC File Number	001-40838
Address of Issuer	777 W. Main Street, Suite 900 Boise IDAHO 83702
Phone	2084331200
Name of Person for Whose Account the Securities are To Be Sold	SOUVIK DAS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	238500.00	288632000	02/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2024	Restricted Stock Units	Issuer			10000	02/28/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SOUVIK DAS 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/08/2026	10000	240825.00
SOUVIK DAS 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/01/2026	41594	1002103.45
SOUVIK DAS 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/31/2025	5273	126992.82
10b5-1 Sales for SOUVIK DAS 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/08/2025	10000	215880.00
10b5-1 Sales for SOUVIK DAS 777 W. Main Street, Suite 900 Boise ID 83702	Common	11/12/2025	20000	404194.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 02/28/2024 through 03/31/2025.
Date of Notice	02/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Souvik Das
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)